Abilify is neither an SSRI nor an SNRI. It belongs to a completely different class of medications called atypical antipsychotics. The confusion is understandable because Abilify is frequently prescribed alongside antidepressants for depression, but it works through a fundamentally different mechanism in the brain.
How Abilify Actually Works
SSRIs and SNRIs are both antidepressants that work by blocking the reabsorption of brain chemicals after they’ve been released. SSRIs target serotonin specifically, while SNRIs target both serotonin and norepinephrine. Common SSRIs include fluoxetine (Prozac) and sertraline (Zoloft). Common SNRIs include venlafaxine (Effexor) and duloxetine (Cymbalta).
Abilify (aripiprazole) takes a different approach entirely. Instead of blocking reabsorption, it acts as a partial agonist at dopamine and serotonin receptors. Think of it like a dimmer switch: when dopamine activity is too high, Abilify dials it down, and when it’s too low, Abilify provides a mild boost. Its intrinsic activity at dopamine receptors is estimated at about 25%, meaning it can effectively reduce dopamine signaling by up to 75% in areas where there’s too much activity. Even a dose as small as 1 mg per day occupies roughly 50% of dopamine receptors once it reaches steady levels in the body.
This dual-action quality is what makes Abilify useful across several different conditions, and it’s also what distinguishes it sharply from the single-track mechanism of SSRIs and SNRIs.
Why It’s Often Prescribed With Antidepressants
The reason so many people associate Abilify with antidepressants is that one of its FDA-approved uses is as an add-on treatment for major depressive disorder in adults. It’s not prescribed on its own for depression. Instead, it’s added when an SSRI or SNRI alone isn’t providing enough relief.
When used this way, the doses are much lower than for its other approved conditions. For depression, the typical starting dose is 2 to 5 mg per day, with a maximum of 15 mg. Compare that to schizophrenia, where starting doses range from 10 to 15 mg and can go up to 30 mg per day. The lower dose reflects its supporting role: Abilify isn’t replacing the antidepressant but fine-tuning the brain’s dopamine and serotonin activity in ways the antidepressant alone can’t.
What Abilify Is FDA-Approved to Treat
Abilify has a broader range of approved uses than most antidepressants, which further highlights how different it is from SSRIs and SNRIs:
- Schizophrenia in adults and adolescents aged 13 to 17
- Manic and mixed episodes in bipolar I disorder in adults and children aged 10 to 17
- Major depressive disorder as an add-on to antidepressants in adults
- Irritability associated with autism in children aged 6 to 17
- Tourette’s disorder in children aged 6 to 18
No SSRI or SNRI carries approvals for schizophrenia or bipolar mania. These conditions involve dopamine dysregulation, which is exactly where Abilify’s mechanism comes into play.
Side Effects Compared to SSRIs and SNRIs
Because Abilify acts on different brain pathways, its side effect profile looks quite different from what you’d expect with an SSRI or SNRI. The most commonly reported side effects include restlessness (called akathisia), anxiety, insomnia, headache, nausea, dizziness, constipation, and fatigue.
Akathisia deserves special attention because it’s one of the most distinctive side effects of Abilify and not something typically associated with antidepressants. People describe it as an internal jitteriness or feeling “wired,” with an inability to sit still. It’s one of the top reasons people discontinue the medication.
Weight gain is another concern with many antipsychotics, though Abilify carries a lower risk in this category than most others in its class. Some people do experience increased appetite, mild weight gain, or changes in blood sugar and cholesterol. SSRIs and SNRIs can also cause weight changes, but through different metabolic pathways. One notable difference: SSRIs and SNRIs are well known for causing sexual side effects, which is less prominent with Abilify.
What This Means if You’re Taking Both
If your prescriber has added Abilify to your existing SSRI or SNRI, the two medications are working on complementary systems. Your antidepressant is increasing serotonin availability (and norepinephrine, if it’s an SNRI), while Abilify is modulating dopamine and serotonin receptor activity. They’re not redundant, and they don’t belong to the same drug class.
The combination is specifically designed for situations where the antidepressant alone isn’t fully managing symptoms. Dose adjustments to Abilify happen gradually, typically no more than 5 mg at a time with at least a week between changes, and your existing antidepressant dose usually stays the same when Abilify is added.